413
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Tazarotene-loaded in situ gels for potential management of psoriasis: biocompatibility, anti-inflammatory and analgesic effect

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 909-918 | Received 15 Feb 2020, Accepted 02 May 2020, Published online: 13 May 2020

References

  • Aksu NB, Yozgatlı V, Okur ME, Ayla Ş, Yoltaş A, Üstündağ Okur N. 2019. Preparation and evaluation of QbD based fusidic acid loaded in situ gel formulations for burn wound treatment. J Drug Deliv Sci Technol. 52:110–121.
  • Aland R, Ganesan M, Rajeswara Rao P. 2019. Development and optimization of tazarotene loaded solid lipid nanoparticles for topical delivery. Asian J Pharm Clin Res. 12:63–77.
  • Algul D, Sipahi H, Aydin A, Kelleci F, Ozdatli S, Yener FG. 2015. Biocompatibility of biomimetic multilayered alginate–chitosan/β-TCP scaffold for osteochondral tissue. Int J Biol Macromol. 79:363–369.
  • Alves DA, Machado D, Melo A, Pereira RFC, Severino P, Hollanda LD, Araújo DR, Lancellotti M. 2016. Preparation of thermosensitive gel for controlled release of levofloxacin and their application in the treatment of multidrug-resistant bacteria. Biomed Res Int. 2016:9702129.
  • Arslan Azizoglu G, Tuncay Tanriverdi S, Aydin Kose F, Ballar Kirmizibayrak P, Ozer O. 2017. Dual-prevention for UV-induced skin damage: incorporation of melatonin-loaded elastic niosomes into octyl methoxycinnamate pickering emulsions. AAPS PharmSciTech. 18:2987–2998.
  • Aryal A, Upreti S. 2017. A brief review on systemic retinoids. Int J Pharm Sci Res. 3:3630–3639.
  • Aytekin AA, Tuncay Tanrıverdi S, Aydın Köse F, Kart D, Eroğlu İ, Özer Ö. 2019. Propolis loaded liposomes: evaluation of antimicrobial and antioxidant activities. J Liposome Res.
  • Bigliardi PL. 2018. Role of skin pH in psoriasis. Curr Probl Dermatol. 54:108–114.
  • Borole P, Chaudhari Y, Dharashivkar S, Kumavat S, Shenghani K, Shah P. 2013. Preparation and evaluation of in situ gel of levofloxacin hemihydrate for treatment of peridontal disease. Int J Pharm Res Biosci. 2:185–196.
  • Chaudhary B, Verma S. 2014. Preparation and evaluation of novel in situ gels containing acyclovir for the treatment of oral herpes simplex virus infections. Sci World J. 2014:280928.
  • Choi HG, Oh YK, Kim CK. 1998. in situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability. Int J Pharm. 165:23–32.
  • Chu K, Chen L, Xu W, Li H, Zhang Y, Xie W, Zheng J. 2013. Preparation of a paeonol-containing temperature-sensitive in situ gel and its preliminary efficacy on allergic rhinitis. Int J Mol Sci. 14:6499–6515.
  • Deshkar SS, Palve VK. 2019. Formulation and development of thermosensitive cyclodextrin-based in situ gel of voriconazole for vaginal delivery. J Drug Deliv Sci Technol. 49:277–285.
  • Eren B, Tuncay Tanrıverdi S, Aydın Köse F, Özer Ö. 2019. Antioxidant properties evaluation of topical astaxanthin formulations as anti-aging products. J Cosmet Dermatol. 18:242–250.
  • Eroğlu İ, Gökçe EH, Tsapis N, Tanrıverdi ST, Gökçe G, Fattal E, Özer Ö. 2015. Evaluation of characteristics and in vitro antioxidant properties of RSV loaded hyaluronic acid–DPPC microparticles as a wound healing system. Colloids Surf B Biointerfaces. 126:50–57.
  • Gadad AP, Wadklar PD, Dandghi P, Patil A. 2016. Thermosensitive in situ gel for ocular delivery of lomefloxacin. Indian J Pharm Educ Res. 50:S96–S105.
  • Gokce EH, Korkmaz E, Dellera E, Sandri G, Cristina Bonferoni M, Ozer O. 2012. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Int J Nanomedicine. 7:1841–1850.
  • Hoque J, Prakash RG, Paramanandham K, Shome BR, Haldar J. 2017. Biocompatible injectable hydrogel with potent wound healing and antibacterial properties. Mol Pharm. 14:1218–1230.
  • Inal O, Yapar EA. 2013. Effect of mechanical properties on the release of meloxicam from poloxamer gel bases. Indian J Pharm Sci. 75:700–706.
  • Jagdale S, Shewale N, Kuchekar BS. 2016. Optimization of thermoreversible in situ nasal gel of timolol maleate. Scientifica. 2016:6401267.
  • Jain S, Addan R, Kushwah V, Harde H, Mahajan RR. 2019. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations. Int J Pharm. 562:96–104.
  • Jensen TS, Finnerup NB. 2014. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol. 13:924–935.
  • Kiemer AK, Vollmar AM. 1997. Effects of different natriuretic peptides on nitric oxide synthesis in macrophages. Endocrinology. 138:4282–4290.
  • Kolle SN, Sullivan KM, Mehling A, van Ravenzwaay B, Landsiedel R. 2012. Applicability of in vitro tests for skin irritation and corrosion to regulatory classification schemes: substantiating test strategies with data from routine studies. Regul Toxicol Pharmacol. 64:402–414.
  • Kose O, Erkekoglu P, Sabuncuoglu S, Kocer-Gumusel B. 2018. Evaluation of skin irritation potentials of different cosmetic products in Turkish market by reconstructed human epidermis model. Regul Toxicol Pharmacol. 98:268–273.
  • Krueger GG, Drake LA, Elias PM, Lowe NJ, Guzzo C, Weinstein GD, Lew-Kaya DA, Lue JC, Sefton J, Chandraratna R. 1998. The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis. Arch Dermatol. 134:57–60.
  • Langasco R, Spada G, Tanriverdi ST, Rassu G, Giunchedi P, Özer Ö, Gavini E. 2016. Bio-based topical system for enhanced salicylic acid delivery: preparation and performance of gels. J Pharm Pharmacol. 68:999–1009.
  • Lauffer F, Jargosch M, Baghin V, Krause L, Kempf W, Absmaier-Kijak M, Morelli M, Madonna S, Marsais F, Lepescheux L, et al. 2020. IL-17C amplifies epithelial inflammation in human psoriasis and atopic eczema. J Eur Acad Dermatol Venereol. 34:800–809.
  • Luo Y, Teng Z, Li Y, Wang Q. 2015. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake. Carbohydr Polym. 122:221–229.
  • Mabuchi T, Chang TW, Quinter S, Hwang ST. 2012. Chemokine receptors in the pathogenesis and therapy of psoriasis. J Dermatol Sci. 65:4–11.
  • Mandal S, Prabhushankar G, Thimmasetty M, Geetha M. 2012. Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride. Int J Pharma Investig. 2:78–82.
  • Marks R. 1999. The role of tazarotene in the treatment of psoriasis. Br J Dermatol. 140:24–28.
  • Mohamed MI, Makky AM, Abdellatif MM. 2013. Liposomal gels as carriers for safer topical delivery of tazarotene. J Pharm Res Opin. 3:82–90.
  • Moore T, Croy S, Mallapragada S, Pandit N. 2000. Experimental investigation and mathematical modeling of Pluronic® F127 gel dissolution: drug release in stirred systems. J Control Release. 67:191–202.
  • Musa SH, Basri M, Fard Masoumi HR, Shamsudin N, Salim N. 2017. Enhancement of physicochemical properties of nanocolloidal carrier loaded with cyclosporine for topical treatment of psoriasis: in vitro diffusion and in vivo hydrating action. Int J Nanomedicine. 12:2427–2441.
  • Nasr M, Abdel-Hamid S. 2016. Optimizing the dermal accumulation of a tazarotene microemulsion using skin deposition modeling. Drug Dev Ind Pharm. 42:1–643.
  • Nicholson B. 2006. Differential diagnosis: nociceptive and neuropathic pain. Am J Manag Care. 12:256–262.
  • Okur ME, Ayla Ş, Batur Ş, Yoltaş A, Genç E, Pertek S, Üstündağ Okur N. 2019. Evaluation of in situ gel containing pycnogenol for cutaneous wound healing. Medeni Med J. 34:67–75.
  • Ozcan I, Abaci O, Uztan AH, Aksu B, Boyacioğlu H, Güneri T, Ozer O. 2009. Enhanced topical delivery of terbinafine hydrochloride with chitosan hydrogels. AAPS PharmSciTech. 10:1024–1031.
  • Patil S, Kadam A, Bandgar S, Patil S. 2015. Formulation and evaluation of an in situ gel for ocular drug delivery of anticonjunctival drug. Cellul Chem Technol. 49:35–40.
  • Pithadia DJ, Reynolds KA, Lee EB, Wu JJ. 2019. Psoriasis-associated cutaneous pain: etiology, assessment, impact, and management. J Dermatolog Treat. 30:435–440.
  • Pradhan M, Alexander A, Singh MR, Singh D, Saraf S, Saraf S, Ajazuddin  2018. Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomed Pharmacother. 107:447–463.
  • Rawat D, Gunjan A, Gupta M, Singh S, Pathak A. 2013. Spectrophotometric and validated RP – HPLC method for the estimation of retinod drug tazarotene in gel. Asian J Pharm Educ Res. 2:72–89.
  • Reich K. 2012. The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatology Venereol. 26:3–11.
  • Sahle FF, Balzus B, Gerecke C, Kleuser B, Bodmeier R. 2016. Formulation and in vitro evaluation of polymeric enteric nanoparticles as dermal carriers with pH-dependent targeting potential. Eur J Pharm Sci. 92:98–109.
  • Sala M, Elaissari A, Fessi H. 2016. Advances in psoriasis physiopathology and treatments: up to date of mechanistic insights and perspectives of novel therapies based on innovative skin drug delivery systems (ISDDS). J Control Release. 239:182–202.
  • Sawant K, Mundada P, Sodani D. 2015. Physicochemical characterization and clinical evaluation of a microemulsion system for topical delivery of tazarotene in psoriasis. MNS. 7:98–107.
  • Şenyiğit T, Padula C, Özer Ö, Santi P. 2009. Different approaches for improving skin accumulation of topical corticosteroids. Int J Pharm. 380:155–160.
  • Şenyiğit T, Sonvico F, Barbieri S, Özer Ö, Santi P, Colombo P. 2010. Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin. J Controlled Release. 142:368–373.
  • Şenyiğit T, Sonvico F, Rossi A, Tekmen I, Santi P, Colombo P, Nicoli S, Özer Ö. 2016. In vivo assessment of clobetasol propionate-loaded lecithin-chitosan nanoparticles for skin delivery. Int J Mol Sci. 18:32.
  • Sheikh A, Sheikh S, Adman S. 2017. Development and characterization of novel in situ gel of moxifloxacin hydrochloride. Asian J Pharm. 11:s616–s624.
  • Siafaka PI, Barmbalexis P, Bikiaris DN. 2016. Novel electrospun nanofibrous matrices prepared from poly(lactic acid)/poly(butylene adipate) blends for controlled release formulations of an anti-rheumatoid agent. Eur J Pharm Sci. 88:12–25.
  • Siafaka PI, Betsiou M, Tsolou A, Angelou E, Agianian B, Koffa M, Chaitidou S, Karavas E, Avgoustakis K, Bikiaris D. 2015. Synthesis of folate- pegylated polyester nanoparticles encapsulating ixabepilone for targeting folate receptor overexpressing breast cancer cells. J Mater Sci Mater Med. 26:1–14.
  • Siafaka PI, Okur ME, Ayla Ş, Er S, Cağlar EŜ, Okur NÜ. 2019. Design and characterization of nanocarriers loaded with Levofloxacin for enhanced antimicrobial activity; physicochemical properties, in vitro release and oral acute toxicity. Brazilian J Pharm Sci. 55:1–13.
  • Siafaka PI, Üstündağ Okur N, Mone M, Giannakopoulou S, Er S, Pavlidou E, Karavas E, Bikiaris D. 2016. Two different approaches for oral administration of voriconazole loaded formulations: electrospun fibers versus β-cyclodextrin complexes. Int J Mol Sci. 17:282.
  • Siafaka PI, Zisi AP, Exindari MK, Karantas ID, Bikiaris DN. 2016. Porous dressings of modified chitosan with poly(2-hydroxyethyl acrylate) for topical wound delivery of levofloxacin. Carbohydr Polym. 143:90–99.
  • Soliman KA, Ullah K, Shah A, Jones DS, Singh T. 2019. Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications. Drug Discov Today. 24:1575–1586.
  • Stüttgen G. 1981. Thermography of psoriasis. effects of retinoids. In: Orfanos CE, Braun-Falco O, Farber EM, Grupper C, Polano MK, Schuppli R, editors. Retinoids. Berlin: Springer.
  • Sue Lee C, Koo J. 2005. A review of acitretin, a systemic retinoid for the treatment of psoriasis. Expert Opin Pharmacother. 6:1725–1734.
  • Tang L, Yang X, Liang Y, Xie H, Dai Z, Zheng G. 2018. Transcription factor retinoid-related orphan receptor γt: a promising target for the treatment of psoriasis. Front Immunol. 9:1210.
  • Tsuruta D. 2009. NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis. Recent Pat Inflamm Allergy Drug Discov. 3:40–48.
  • Tuncay Tanrıverdi S, Cheaburu-Yilmaz CN, Carbone S, Özer Ö. 2018. Preparation and in vitro evaluation of melatonin-loaded HA/PVA gel formulations. Pharm Dev Technol. 23:815–825.
  • Tuncay Tanrıverdi S, Hilmioğlu Polat S, Yeşim Metin D, Kandiloğlu G, Özer Ö. 2016. Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis: in vitro and in vivo evaluation. J Liposome Res. 26:163–173.
  • Üstündağ Okur N, Apaydın Ş, Karabay Yavaşoğlu NÜ, Yavaşoğlu A, Karasulu HY. 2011. Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations. Int J Pharm. 416:136–144.
  • Üstündağ Okur N, Çağlar EŞ, Arpa MD, Karasulu HY. 2017. Preparation and evaluation of novel microemulsion-based hydrogels for dermal delivery of benzocaine. Pharm Dev Technol. 22:500–510.
  • Üstündağ Okur N, Filippousi M, Okur ME, Ayla Ş, Çağlar EŞ, Yoltaş A, Siafaka PI. 2018. A novel approach for skin infections: controlled release topical mats of poly(lactic acid)/poly(ethylene succinate) blends containing Voriconazole. J Drug Deliv Sci Technol. 46:74–86.
  • Üstündağ Okur N, Gökçe EH, Bozbıyık Dİ, Eğrilmez S, Ertan G, Özer Ö. 2015. Novel nanostructured lipid carrier based inserts for controlled ocular drug delivery: evaluation of corneal bioavailability and treatment efficacy on bacterial keratitis. Expert Opin Drug Del. 12:1791–1807.
  • Üstündağ Okur N, Hökenek N, Okur ME, Ayla Ş, Yoltaş A, Siafaka PI, Cevher E. 2019. An alternative approach to wound healing field; new composite films from natural polymers for mupirocin dermal delivery. Saudi Pharm J. 27:738–752.
  • Üstündağ Okur N, Yozgatlı V, Okur ME, Yoltaş A, Siafaka PI. 2019. Improving therapeutic efficacy of voriconazole against fungal keratitis: thermo-sensitive in situ gels as ophthalmic drug carriers. J Drug Deliv Sci Technol. 49:323–333.
  • Yu B, Ma P, Yuan L, Chen D, Yang J. 2015. Evaluation of change in the skin concentration of tazarotene and betamethasone dipropionate based on drug–drug interaction for transdermal drug delivery in miniature pig. Xenobiotica. 45:380–384.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.